APCs	antigen presenting cells
BC	breast cancer
BDCA	blood dendritic cell antigens
cDCs	conventional dendritic cells
CMF	cyclophosphamide/methotrexate/5-fluorouracil
DCIS	ductal carcinoma in situ
DCs	dendritic cells
DC-LAMP	dendritic-cell-lysosome-associated membrane glycoprotein
DC-SIGN	dendritic-cell-specific intercellular-adhesion-molecule-3-grabbing non-integrin
ER	estrogen receptor
FISH	fluorescence in situ hybridization
Flt3L	FMS-like tyrosine kinase 3 ligand
HER2	human epidermal growth factor receptor 2
HIF-1α	hypoxia inducible factor-1α
ICOSL	inducible costimulatory ligand
IDO	indoleamine 2,3-dioxygenaze
IFN	interferon
MHC	major histocompatibility complex
NAC	neoadjuvant chemotherapy
NK cells	natural killer cells
pCR	pathological complete response
pDCs	plasmacytoid dendritic cells
PD-L1	programmed death-ligand 1
PR	progesterone receptor
PRRs	pattern recognition receptors
RCB	residual cancer burden
SLNs	sentinel lymph nodes
TGF-β	transforming growth factor-β
TLR	toll-like receptor
TNBC	triple-negative breast cancer
TNF-α	tumor necrosis factor-α
VEGF	vascular endothelial growth factor